Ramiro Sanchez, Chief Medical Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 10,000 shares at $42.47 ($425K) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Scheduled sale ($425k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CERE | SELL | 2023-12-11 | $414K | — | Filing → |